Everest Kanto Cylinder Limited — Q3 FY26
Everest Kanto delivered a strong Q3 FY26 with consolidated EBITDA up 48% YoY to ₹59.2 crore and PAT surging 98.9% to ₹35.7 crore.
bullish
high
✓ Verified against BSE filing
Indian management teams deliver on roughly 12% of specific earnings-call promises. A low score does not indicate dishonesty — it reflects how aspirational forward guidance typically is.
Q2 FY26
Egypt plant trial production by January 2026
The Egypt facility is expected to begin trial production by January 2026.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1
Q2 FY26
Mundra plant commercialization by March 2026
The Mundra plant is expected to be commercialized by March 2026.
Missed
Current-quarter commentary contains related risk or weakness, so the promise appears not to have been delivered yet.
heuristic_v1